MSTN and neuromuscular disease: Myostatin is produced in the muscle, and as muscles from patients and animals with neuromuscular diseases are often smaller than healthy muscles, one possibility is that reduced circulating myostatin is simply due to reduced muscle size and not reduced production of myostatin per unit muscle mass.